Groupe la Francaise Buys Shares of 30,000 Walgreens Boots Alliance, Inc. $WBA

Key Points

• Groupe la Francaise has acquired 30,000 shares of Walgreens Boots Alliance valued at approximately $335,000 in the first quarter of 2023.
• Other institutional investors have also increased their stakes in Walgreens, with notable increases in holdings by Colonial Trust Co SC and Federated Hermes Inc..
• Walgreens Boots Alliance reported a quarterly EPS of $0.38, beating analyst expectations of $0.34, with a revenue of $38.99 billion during the quarter, reflecting a 7.2% year-over-year increase.

Groupe la Francaise bought a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 30,000 shares of the pharmacy operator's stock, valued at approximately $335,000.

A number of other institutional investors also recently made changes to their positions in WBA. Colonial Trust Co SC increased its holdings in shares of Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock valued at $27,000 after acquiring an additional 1,297 shares during the last quarter. Sentry Investment Management LLC bought a new stake in shares of Walgreens Boots Alliance in the 1st quarter valued at approximately $27,000. Curat Global LLC bought a new stake in shares of Walgreens Boots Alliance in the 1st quarter valued at approximately $27,000. Federated Hermes Inc. increased its holdings in shares of Walgreens Boots Alliance by 135.8% in the 1st quarter. Federated Hermes Inc. now owns 3,152 shares of the pharmacy operator's stock valued at $35,000 after acquiring an additional 1,815 shares during the last quarter. Finally, N.E.W. Advisory Services LLC bought a new stake in shares of Walgreens Boots Alliance in the 1st quarter valued at approximately $43,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $12.07 on Monday. The company has a market cap of $10.45 billion, a P/E ratio of -1.66, a PEG ratio of 1.42 and a beta of 0.80. The stock has a fifty day moving average price of $11.63 and a 200 day moving average price of $11.19. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $13.25.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.34 by $0.04. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%.The firm had revenue of $38.99 billion during the quarter, compared to the consensus estimate of $36.72 billion. During the same period in the prior year, the business earned $0.63 EPS. The firm's revenue was up 7.2% on a year-over-year basis. On average, research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. UBS Group reiterated a "neutral" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Wall Street Zen began coverage on Walgreens Boots Alliance in a research note on Wednesday, May 21st. They set a "hold" rating for the company. Finally, Morgan Stanley restated an "underweight" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Two analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Reduce" and a consensus price target of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.